Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roos Van Elzen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Chemistry|May 17, 2021
<i>In Vitro</i> and <i>In Situ</i> Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived ProbesYentl Van Rymenant, Muhammet Tanc, Roos Van Elzen, et al.
Biochimica Et Biophysica Acta|April 12, 2008
The proteome of the human neuroblastoma cell line SH-SY5Y: an enlarged proteomeKambiz Gilany, Roos Van Elzen, Kim Mous, et al.
Journal of Medicinal Chemistry|November 6, 2012
P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathyPieter Van der Veken, Vilmos Fülöp, Dean Rea, et al.
Biochimie|February 21, 2025
The prolyl oligopeptidase and α-synuclein connection revisitedRoos Van Elzen, Yannick Waumans, Sangeeta Nath, et al.
Journal of Cell Science|August 28, 2016
Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitroKülli Jaako, Alexander Waniek, Keiti Parik, et al.
European Journal of Medicinal Chemistry|August 22, 2017
Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profilingDean Rea, Roos Van Elzen, Hans De Winter, et al.
Cancer Immunology Research|January 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial CancerMatthew D Galsky, Mark Kockx, Juliette Roels, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Chemistry|May 17, 2021
<i>In Vitro</i> and <i>In Situ</i> Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived ProbesYentl Van Rymenant, Muhammet Tanc, Roos Van Elzen, et al.
Biochimica Et Biophysica Acta|April 12, 2008
The proteome of the human neuroblastoma cell line SH-SY5Y: an enlarged proteomeKambiz Gilany, Roos Van Elzen, Kim Mous, et al.
Journal of Medicinal Chemistry|November 6, 2012
P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathyPieter Van der Veken, Vilmos Fülöp, Dean Rea, et al.
Biochimie|February 21, 2025
The prolyl oligopeptidase and α-synuclein connection revisitedRoos Van Elzen, Yannick Waumans, Sangeeta Nath, et al.
Journal of Cell Science|August 28, 2016
Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitroKülli Jaako, Alexander Waniek, Keiti Parik, et al.
European Journal of Medicinal Chemistry|August 22, 2017
Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profilingDean Rea, Roos Van Elzen, Hans De Winter, et al.
Cancer Immunology Research|January 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial CancerMatthew D Galsky, Mark Kockx, Juliette Roels, et al.
Pageof 2